benzbromarone has been researched along with trolamine salicylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, TF | 1 |
| Rodnan, GP | 1 |
| Chen, X; Gao, Z; Xu, H; Zhan, L; Zheng, Y; Zhou, X | 1 |
1 review(s) available for benzbromarone and trolamine salicylate
| Article | Year |
|---|---|
Treatment of the gout and other forms of crystal-induced arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzbromarone; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Kidney; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1982 |
2 other study(ies) available for benzbromarone and trolamine salicylate
| Article | Year |
|---|---|
Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
Topics: Adult; Aged; Arthritis; Benzbromarone; Benzofurans; Chemical Phenomena; Chemistry; Chronic Disease; Gout; Humans; Hydrochlorothiazide; Kinetics; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
Activation of peripheral KCNQ channels relieves gout pain.
Topics: Action Potentials; Animals; Animals, Newborn; Arthritis; Benzbromarone; Cells, Cultured; CHO Cells; Cricetulus; Disease Models, Animal; Formaldehyde; Ganglia, Spinal; Hippocampus; Inflammation; KCNQ2 Potassium Channel; Male; Mice; Mice, Inbred Strains; Neurons; Rats; Rats, Sprague-Dawley; Uric Acid; Uricosuric Agents | 2015 |